Methotrexate Prophylaxis
Methotrexate Prophylaxis is a pharmacological intervention involving the administration of methotrexate as a disease-modifying agent to prevent graft-versus-host disease in the context of hematopoietic stem cell transplantation.
386
Publications
26.3K
Citations
2.6K
Authors
801
Institutions
Publications per year
2017–2026
52
386
Rainer Storb, H. Joachim Deeg, John Whitehead et al. · New England Journal of Medicine · 1986 · 1.5K citations
Medicine, Hematology, Immunology +14
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Hyon K. Choi, Miguel A. Hernán, John D. Seeger et al. · The Lancet · 2002 · 1.1K citations
Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations
Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations
1–5 of 386
2.6K
17
h-index
16
h-index
12
h-index
11
h-index
11
h-index
1–5 of 2.6K
801
Dana-Farber Cancer Institute
Boston, United States
14 h-index
86 publications
7.8K citations
Fred Hutch Cancer Center
Seattle, United States
14 h-index
138 publications
52.6K citations
University of Michigan
Ann Arbor, United States
11 h-index
56 publications
14.7K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
11 h-index
106 publications
8.2K citations

University of Alabama at Birmingham
Birmingham, United States
10 h-index
18 publications
1.4K citations
Harvard University
Cambridge, United States
10 h-index
63 publications
10.9K citations

University of Minnesota
Minneapolis, United States
10 h-index
28 publications
4.7K citations
Memorial Sloan Kettering Cancer Center
New York, United States
10 h-index
53 publications
4.1K citations
1–8 of 801
32 publications · 3.4K citations
26
h-index
Repository · 46 publications · 2.9K citations
24
h-index
22 publications · 1.6K citations
22
h-index
15 publications · 1.5K citations
15
h-index
TCT · 17 publications · 1K citations
15
h-index
1–5